https://www.selleckchem.com/pr....oducts/tofa-rmi14514
6 for KSKS. The MCID determined by anchor-based ROC was between 15 and 20 for KSFS (AUC satisfaction=71.8%, survivorship=61.4%) and between 33 and 34 for KSKS (AUC satisfaction=76.3%, survivorship=67.1%). The MCID determined by distribution-based method of 0.5 SD was 11.7 for KSFS and 11.9 for KSKS. The MCID of 6.3 points for KSFS, and 6.6 points for KSKS, is a useful benchmark for future studies looking to compare revision against primary TKA outcomes. Clinically, the MCID between 15 and 20 for KSFS and between 33 and 34 for KSKS
Gefällt mir
Kommentar
Teilen
